Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
4.430
+0.100 (2.31%)
Sep 15, 2026, 2:38 PM EDT - Market open
Immuneering Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Immuneering stock has a consensus rating of "Strong Buy" and an average price target of $17.17. The average 1-year stock price forecast is 287.58% higher than the current stock price, while the lowest is $12 (+170.88%) and the highest is $30 (+577.20%).
Price Target: $17.17 (+287.58%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Immuneering stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $14 | Buy | Maintains | $14 | +216.03% | Aug 27, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 | Buy | Maintains | $12 | +170.88% | Aug 17, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $12 | Buy | Maintains | $12 | +170.88% | Aug 6, 2026 |
| Needham | Needham | Buy Reiterates $11 → $18 | Buy | Reiterates | $11 → $18 | +306.32% | Aug 5, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $17 | Buy | Initiates | $17 | +283.75% | Jul 8, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
19.50M
EPS This Year
-1.12
from -1.27
EPS Next Year
-1.26
from -1.12
EPS and Forward PE are based on non-GAAP adjusted numbers.